Скачать или смотреть What can we learn from the Cerivastatin market withdrawal?

In 2001, a statin product from Bayer known as Baycol(r) (also sold as Lipobay(r)) with the generic name cerivastatin was pulled from the market in the US and most of the world. In this video, I take a look at the history of that decision, not to throw stones, but to see what we as patients can learn from this incident. What does it tell us about our own responsibility for due diligence when being prescribed a drug?

Notes:

A couple of times I switched from "milligrams" to "micrograms" when speaking. While this was unintentional, the figures I used are accurate: 1,000 micrograms = 1 milligram, so 0.4 milligrams is 400 micrograms, etc.

[1] Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis
https://jamanetwork.com/journals/jama...
Psaty BM, Furberg CD, Ray WA, Weiss NS. Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis. JAMA. 2004;292(21):2622–2631. doi:10.1001/jama.292.21.2622

-------------------------------------
DISCLAIMER: The following presentation and all presentations on this channel are for informational purposes only and should not be used to diagnose or treat any medical condition. Please consult with your personal physician when deciding whether to treat or not treat any condition with pharmaceuticals or by any other treatment or therapy. In particular, never change dosage, stop taking medications, or change a therapy because of something presented in this series without discussing your options with your primary care physician or other health professional.

The author is not a medical professional and is presenting his own story, research, and opinions as they apply to himself, and himself alone.

If you think you may be experiencing a medical emergency, immediately call your doctor or dial 911.
-----------------------------------